Moody Aldrich Partners LLC Sells 64,980 Shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO)

Moody Aldrich Partners LLC lessened its position in BridgeBio Pharma, Inc. (NASDAQ:BBIO – Free Report) by 44.9% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 79,873 shares of the company’s stock after selling 64,980 shares during the period. Moody […]

Related Keywords

Neil Kumar ,Raymond James ,Brianc Stephenson ,Bio Pharma ,Nasdaq ,Moody Aldrich Partners ,Goldman Sachs Group ,Bridgebio Pharma Inc ,Jpmorgan Chase Co ,Moody Aldrich Partners Llc Bio Pharma ,Daiwa Securities Group Inc ,Manufacturers Life Insurance Company ,Analysts Bio Pharma Inc ,Exchange Commission ,Securities Exchange Commission ,Bridgebio Pharma Company Profile ,Kokusai Asset Management Co ,Mitsubishi Ufj ,Nisa Investment Advisors ,Group Plc ,Bio Pharma Inc ,Bridgebio Pharma ,Free Report ,Aldrich Partners ,General Group Plc ,Investment Advisors ,Securities Group ,Asset Management ,Get Free Report ,Visit Holdingschannel ,Bridgebio Pharma Daily ,Nasdaq Bbio ,Ebbio ,Medical ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,